INTERNATIONAL PATENT: PROQR THERAPEUTICS II B.V. FILES APPLICATION FOR "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF HUNTINGTON'S DISEASE"

GENEVA, July 1 -- PROQR THERAPEUTICS II B.V. (Zernikedreef 92333 CK Leiden) filed a patent application (PCT/EP2024/087289) for "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF HUNTINGTON'S DISEASE" on Dec 18, 2024. With publication no. WO/2025/132708, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOLKERS, Maarten (ProQR Therapeutics ll B.V.Zernikedreef 92333 CK Leiden), DOYLE, Christopher Kuyler (ProQR Therapeutics ll B.V.Zernikedreef 92333 CK Leiden), KLEIN, Bart (ProQR Therapeutics ll B.V.Zernikedreef 92333 CK Leiden)...